EP Patent

EP1819700B1 — Potassium salt of an hiv integrase inhibitor

Assigned to Istituto di Ricerche di Biologia Molecolare P Angeletti SpA · Expires 2011-11-23 · 14y expired

What this patent protects

Potassium salts of Compound A disclosed, wherein Compound A is of formula (I). Compound A is an HIV integrase inhibitor useful for treating or prophylaxis of HIV infection, for delaying the onset of AIDS, and for treating or prophylaxis of AIDS.

USPTO Abstract

Potassium salts of Compound A disclosed, wherein Compound A is of formula (I). Compound A is an HIV integrase inhibitor useful for treating or prophylaxis of HIV infection, for delaying the onset of AIDS, and for treating or prophylaxis of AIDS.

Drugs covered by this patent

Patent Metadata

Patent number
EP1819700B1
Jurisdiction
EP
Classification
—
Expires
2011-11-23
Drug substance claim
No
Drug product claim
No
Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.